CERo Therapeutics (CERO) News Today $0.75 -0.01 (-1.83%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.70 -0.06 (-7.46%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cero Therapeutics set to initiate enrollment of Phase 1 trial of CER-1236March 29 at 12:22 AM | markets.businessinsider.comCERo Therapeutics Holdings, Inc. Poised to Initiate Enrollment of Phase 1 Trial of CER-1236 in AML Following Positive FDA Review of ManufacturingMarch 27 at 8:15 AM | globenewswire.comCERo enters manufacturing agreement with University of California DavisMarch 20, 2025 | markets.businessinsider.comCERO Flat on Leukemia Drug DevelopmentsMarch 19, 2025 | baystreet.caCERo Therapeutics Partners With University Of California Davis For Manufacturing Lead Compound For Treating Cancer: Retail Stays BullishMarch 19, 2025 | msn.comCERo Therapeutics Holdings, Inc. Continues to Progress Toward Initial Dosing of Patients in ...March 19, 2025 | gurufocus.comCERo Therapeutics Holdings, Inc. Continues to Progress Toward Initial Dosing of Patients in Phase 1 Trial with Agreement with University of California Davis for Manufacturing ServicesMarch 19, 2025 | globenewswire.comCERo Therapeutics reveals promising preclinical ovarian cancer studyMarch 15, 2025 | uk.investing.comCero Therapeutics presents preclinical data on CER-1236 at SITC Spring meetingMarch 14, 2025 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data Demonstrating CER-1236 May be Targeted to Ovarian Cancer Cells Without Toxicities at 2025 SITC Spring Scientific Cellular Therapy for Solid Tumors MeetingMarch 13, 2025 | globenewswire.comCero Therapeutics announces progress in initiation of Phase 1 trialMarch 6, 2025 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational AssaysMarch 6, 2025 | globenewswire.comCERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14March 5, 2025 | globenewswire.comCERO stock touches 52-week low at $1.75 amid market challengesFebruary 11, 2025 | msn.comCero Therapeutics reports current cash position of $8MFebruary 6, 2025 | markets.businessinsider.comCERo Therapeutics strengthens cash reserves, advances clinical trialsFebruary 6, 2025 | msn.comCERo Therapeutics to raise $5M via ATM offeringFebruary 6, 2025 | msn.comCero Therapeutics prices $5M at-the-market offeringFebruary 6, 2025 | msn.comCERo Therapeutics Holdings, Inc. Highlights ProgressFebruary 6, 2025 | globenewswire.comCERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq RulesFebruary 5, 2025 | globenewswire.comCERo Therapeutics Holdings IncJanuary 21, 2025 | morningstar.comCERO Therapeutics secures NASDAQ compliance extensionJanuary 21, 2025 | msn.comCERO Stock trading halted, news pendingJanuary 9, 2025 | markets.businessinsider.comCERo Therapeutics (NASDAQ:CERO) Sets New 12-Month Low - Time to Sell?CERo Therapeutics (NASDAQ:CERO) Reaches New 52-Week Low - Should You Sell?January 8, 2025 | marketbeat.comCero Therapeutics to effect 1-for-100 reverse stock splitJanuary 7, 2025 | finance.yahoo.comCERo Therapeutics Holdings, Inc. Announces Reverse Stock SplitJanuary 6, 2025 | gurufocus.comCero Therapeutics files to sell common stock, warrants, no amount givenDecember 23, 2024 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. (CEROW)December 17, 2024 | finance.yahoo.comCERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Bioventures Opportunities G. Yk Sells 1,343,801 SharesDecember 14, 2024 | insidertrades.comBioventures Opportunities G. Yk Sells 850,543 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) StockDecember 11, 2024 | insidertrades.comCero Therapeutics names Chris Ehrlich as CEODecember 7, 2024 | markets.businessinsider.comCERo Therapeutics Appoints New CEO to Lead InnovationsDecember 6, 2024 | markets.businessinsider.comCERo Therapeutics, Inc. Appoints Chris Ehrlich CEODecember 6, 2024 | globenewswire.comCero Therapeutics files to sell 210M shares of common stock for holdersNovember 28, 2024 | markets.businessinsider.comCERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells $53,248.60 in StockNovember 21, 2024 | insidertrades.com3 Penny Stocks to Watch Now, 11/19/24November 19, 2024 | msn.comCero Therapeutics receives FDA clearance of IND application for CER-1236November 16, 2024 | markets.businessinsider.comBioventures Opportunities G. Yk Sells 3,250,000 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) StockNovember 15, 2024 | insidertrades.comCERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous LeukemiaNovember 15, 2024 | globenewswire.comCero Therapeutics presents preclinical data on CER-1236November 13, 2024 | markets.businessinsider.comCERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer DataNovember 13, 2024 | msn.comCERo Therapeutics Stock Is Soaring Monday: What's Going On?November 11, 2024 | benzinga.comCERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without ToxicityNovember 11, 2024 | globenewswire.comCero Therapeutics submits IND clinical hold CRL to the FDAOctober 22, 2024 | markets.businessinsider.comCERo Therapeutics files to sell 713.6M shares of common stock for holdersOctober 21, 2024 | msn.comCERo Therapeutics, Inc. Provides Corporate UpdateOctober 21, 2024 | globenewswire.comCERo Therapeutics appoints new CFO and CDOOctober 4, 2024 | investing.comCERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development OfficerOctober 2, 2024 | globenewswire.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News SummarySeptember 25, 2024 | benzinga.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock, Short Interest ReportSeptember 25, 2024 | benzinga.com Remove Ads Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address CERO Media Mentions By Week CERO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERO News Sentiment▼0.300.79▲Average Medical News Sentiment CERO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERO Articles This Week▼41▲CERO Articles Average Week Remove Ads Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MBRX News BLRX News TLPH News QNTM News PHXM News TRAW News APLM News PRPH News TXMD News KPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERO) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
